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Letters to the Editor
Urinary pH, melamine, and 
kidney stone formation
Sir,
A recent publication on urinary pH, melamine, and 
kidney stone formation is very interesting.[1] Lu et al. 
reported “an association of  gender and urinary pH with 
melamine-associated kidney stone formation risk”.[1] This 
can be useful epidemiological information. However, some 
facts of  medical biochemistry should be discussed. The 
reported pH in this publication is not clear. Only a value 
of  < and ≥6.5 can be read. Indeed, the correlation can 
be directly assessed by the correlation study between the 
exact urine pH value and solubility. Based on chemical 
structure, melamine is a base and increases solubility in 
acidic conditions (very good if  pH is lower than 4).[2] 
However, it is a fact that the range of  human urine pH is 
not wide (4.5–8); hence, the solubility of  melamine might 
be affected slightly.
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Comment on: Laparoscopic 
transperitoneal 
ureterolithotomy for large 
ureteric stone
Sir,
I read with great interest the article titled “Laparoscopy 
transperitoneal ureterolithotomy for large ureteric stone” by Al-
Sayyad.[1] The report is very informative, with some insight into 
the current trend of  large proximal ureteric stone management. 
I have some comments on this work. Due to the nature of  
retrospective study, the value of  this report is limited. The 
author did not define the meaning of  large proximal ureteric 
stone clearly. In most of  previous studies this classification was 
precise in term of size and site of  ureteric stone. As an example 
Geol et al.[2] classify it as stone located between the ureteropelvic 
junction and the lower border of the 4th lumbar vertebra, whereas 
Cengiz et al.[3] use 5 cm distal to the ureteropelvic junction. 
Goel et al.[2] found that the best option for those types of  stone 
is percutaneous nephrolithotomy (PCNL) which give stone 
free rate of  98.5%. This success rates were almost similar to 
laparoscopic ureterolithotomy done by the author.[1] In contrast 
the laparoscopic ureterolithotomy in this study showed higher 
morbidity in comparison to the PCNL in Goel et al.[2] These 
shown by longer operative time (mean of  90 vs. 47 minutes) 
and longer hospital stay (mean of  62.4 vs. 46 hours).[1,2] If  
we treat the patient individually with precise diagnosis of  site 
and size of  stone, the choice of  treatment mode will be more 
accurate. Endourology procedures are documented as minimal 
invasive procedure with very low morbidity, but highly operator 
dependent. I would say that the best option for stone located close 
to ureteropelvic junction (5 cm) is PCNL. This endourology 
procedure will give high success rate with reasonable morbidity 
in an expert hand. Laparoscopic ureterolithotomy only reserve 
for those cases which was contraindicated for PCNL.
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Inflammatory 
myofibroblastic tumors of 
the bladder
Sir,
I read with great interest the article by Yagnik et al.[1] regarding 
inflammatory myofibroblastic tumor (IMT) of the bladder. The 
authors have succinctly described the pathology with relevant 
pictures. I congratulate the authors for the write up. The article 
however fails to provide details pertinent to this entity in general 
and the case in specific. After review of  current literature,[2,3] 
I would like to raise a few questions and make a few points
First, the authors in the article describe an “irregular 
heterogeneously enhancing polypoidal bladder base lesion 
infiltrating bilateral seminal vesicle” on CT imaging; however, 
no pictures are provided. A contrast-enhanced CT scan picture 
would have given a wealth of  information to the readers. The 
readers would have become wise if  further information was 
provided on lymph nodes, given the fact that the mass had 
suspicion of  involvement of  the seminal vesicles and the 
prostate.
Second, the authors describe having taken “multiple biopsies” 
from the tumor. They do not mention if  the biopsy included 
the muscle. Did the authors completely resect the tumor? The 
article does not throw any light on this fact.
Third, as it is famously said” the proof  of  the pudding is in 
eating it”. The authors state in the article that these tumors 
tend to reccur. I would be more worried, if  the tumor reccurs, 
particularly so if  the tumor was not completely resected at the 
first instance. A postoperative imaging study of  the patient in 
the form of  either an ultrasound or CT imaging would have 
educated the readers.
Last but not the least, the authors describe a well-described rare 
entity,[2,3] but it would have gone a long way for the readers, 
if  the authors had addressed the dilemmas with imaging, core 
issue of  recurrence and the importance of  follow-up in IMTs.
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